Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
J Eur Acad Dermatol Venereol ; 37(3): 573-580, 2023 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-36331365

RESUMEN

BACKGROUND: Rosacea is a common chronic inflammatory facial skin disorder. Standardized evaluation of the severity and extent of rosacea is important for baseline assessment and treatment effect. The currently used Investigator's Global Assessment (IGA) is unspecific and fails to consider subtypes/phenotypes of rosacea and area involvement. The Rosacea Area and Severity Index (RASI) was developed to give a more nuanced evaluation of rosacea features in four facial skin areas adjusted to the relative importance of each area of the face to obtain an overall severity score. OBJECTIVES: To validate RASI against the IGA and to assess the inter- and intraobserver reliability for RASI. METHODS: Sixteen dermatologists evaluated photographs of 60 adult patients with rosacea (3 photographs per patient, one from the front and one from each side). IGA and RASI scores were performed for interobserver reliability assessment. To determine intraobserver reliability, 14 dermatologists evaluated 10 other patients twice with at least 1 week interval. RESULTS: The IGA and RASI correlated well (Spearman correlation coefficient (SCC) = 0.75, 95% confidence interval (CI) = 0.72-0.78). Interobserver reliability was moderate for RASI and poor to moderate for IGA. Reliability was strongest for rhinophyma, followed by papules/pustules and erythema, and rather weak for telangiectasia. For area scores, interobserver reliability was strongest for cheeks, followed by nose, chin and forehead. We found a moderate-to-strong intraobserver agreement both for IGA and RASI. CONCLUSIONS: We have designed a new practical tool to examine clinical severity of rosacea. RASI proved simple and reliable in scoring clinical severity of rosacea with an agreement comparable to the currently used IGA although RASI will provide a more nuanced view of the current rosacea extent and severity. We suggest that RASI is used in the daily clinical setting as well as in clinical studies assessing the efficacy of rosacea therapies.


Asunto(s)
Rosácea , Humanos , Reproducibilidad de los Resultados , Rosácea/diagnóstico , Rosácea/tratamiento farmacológico , Piel , Eritema , Inmunoglobulina A , Índice de Severidad de la Enfermedad
2.
Ugeskr Laeger ; 183(11)2021 03 15.
Artículo en Danés | MEDLINE | ID: mdl-33734075

RESUMEN

This case report describes a patient with colonic Crohn's disease and perianal disease. The patient experienced extensive and severe pyoderma gangrenosum after colectomy. Steroids and anti-inflammatory medication had no effect on pyoderma or the persistent perianal and rectal disease. All pyoderma lesions eventually healed after proctectomy and excision of perianal fistulae. The relevance and effect of surgically induced remission on medically resistant inflammatory bowel disease-associated pyoderma gangrenosum is highlighted.


Asunto(s)
Enfermedad de Crohn , Enfermedades Inflamatorias del Intestino , Piodermia Gangrenosa , Colectomía , Enfermedad de Crohn/tratamiento farmacológico , Enfermedad de Crohn/cirugía , Humanos , Piodermia Gangrenosa/tratamiento farmacológico , Piodermia Gangrenosa/etiología , Cicatrización de Heridas
3.
Dermatol Ther ; 33(3): e13432, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-32314487

RESUMEN

Climatotherapy (CT) is a treatment with immediate high clearance rate for chronic psoriasis, but evidence of long-term effects is scarce. Assessment of the impact of a single CT treatment on disease activity and quality of life was carried out at 4- to 6-month follow-ups. A prospective study of patients with psoriasis undergoing 4 weeks of CT in Israel describes long-term outcomes of CT. Psoriasis Area Severity Index (PASI) and Dermatology Life Quality Index (DLQI) scores were assessed before CT and at an average of 5 months after return. Assessment of the eligibility for CT takes place twice a year. A total of 49 patients (28/21 M/F) participated. Pretreatment PASI was 2.6 to 18.7 (mean 8.1 ± 3.8) vs control PASI 0 to 16.9 (mean 5 ± 2.8), (P < .0001). Mean ΔPASI was 3.2 (39.5% reduction). PASI 75 was achieved by 11/49 patients; 10/49 had increased PASI. The mean DLQI score was 16.1 (range 2-30); 10.6 at follow-up (range 0-28), and 33 patients achieved DLQI minimal clinically important difference (P < .0001). Age, sex, number of previous CT, and duration of observation period did not affect endpoints. CT and unmonitored self-treatment induces PASI 75 in one-fifth patients at follow-up 4 to 6 months later. Six of 10 patients report a clinically important improvement of patients' quality of life as measured by DLQI.


Asunto(s)
Climatoterapia , Psoriasis , Humanos , Israel , Estudios Prospectivos , Psoriasis/diagnóstico , Psoriasis/terapia , Calidad de Vida , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
5.
Acta Derm Venereol ; 97(4): 426-432, 2017 Apr 06.
Artículo en Inglés | MEDLINE | ID: mdl-27958611

RESUMEN

Methotrexate (MTX) has been used in the treatment of psoriasis and other dermatological diseases for more than 50 years. However, there is limited evidence regarding its effect, dose and monitoring, and a lack of consensus regarding how the drug should be used in daily practice. Although the use of MTX is governed by guidelines, such as the European S3-Guidelines and the National Institute for Health and Care Excellence (NICE) guideline, it is important to discuss and adjust these guidelines to national standards. An expert meeting was held in Denmark at the end of 2014, in order to reach consensus regarding the use of MTX in dermatological practice in Denmark. Participants included dermatologists, hepatologists, paediatricians, clinical biochemists and a rheumatologist. Topics discussed were: liver disease monitoring, teratogenic effects of MTX, risk of cancer, and use of MTX in children. We report here the conclusions of this expert meeting regarding use of MTX in dermatological practice.


Asunto(s)
Dermatología/normas , Inmunosupresores/administración & dosificación , Metotrexato/administración & dosificación , Psoriasis/tratamiento farmacológico , Adulto , Factores de Edad , Enfermedad Hepática Inducida por Sustancias y Drogas/diagnóstico , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Niño , Consenso , Dinamarca , Cálculo de Dosificación de Drogas , Femenino , Humanos , Inmunosupresores/efectos adversos , Pruebas de Función Hepática , Masculino , Metotrexato/efectos adversos , Neoplasias/inducido químicamente , Neoplasias/diagnóstico , Seguridad del Paciente , Embarazo , Complicaciones del Embarazo/inducido químicamente , Complicaciones del Embarazo/diagnóstico , Psoriasis/diagnóstico , Psoriasis/inmunología , Medición de Riesgo , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento
6.
Dermatol Reports ; 8(1): 6387, 2016 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-27942368

RESUMEN

Rosacea is a field within dermatology with new insight within immunological research and new treatment-algorithm. Patient education on rosacea and appropriate treatments is an important aspect in helping patients succeed with therapy. Treatment should be tailored to each individual patient, taking into account: symptoms, trigger factors, patients' wishes, most bothersome symptoms, psychological aspect, individual needs. A combination of clinical therapies to treat different symptoms concomitantly may offer the best possible outcomes for the patient. In this review article we describe these aspects.

7.
Clin Case Rep ; 4(10): 1012, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27761258

RESUMEN

Papillomatosis cutis lymphostatica is a benign, usually asymptomatic and underreported condition resulting from primary lymphedema or damage of lymphatic vessels due to diabetes. Cases have only been published sporadically. The presented image may help future colleagues to establish the diagnosis.

8.
Int J Low Extrem Wounds ; 15(4): 320-324, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27694303

RESUMEN

The use of a validated screening questionnaire to identify individuals with chronic leg ulcers allows large-scale population-based studies to be conducted that measure and monitor the prevalence of the disease. The aim of this study was to design and validate such a screening questionnaire to identify patients with chronic leg ulcers. A simple 3-item questionnaire was developed at the Department of Dermatology, University Hospital of Zealand, Denmark. In total, 90 patients attending the department's outpatient clinic for dermatological diseases and chronic wounds were included in this study. All included participants completed the questionnaire and were subsequently examined by dermatologists. We found that the constructed 3-item questionnaire in this study had a sensitivity and specificity of 95% and 93% and a positive predictive value and negative predictive value of 78% and 95%, respectively. Moreover, we found that the use of the 3-item questionnaire, as compared with a single question, in which the participants were asked whether they currently have a leg ulcer, resulted in significantly higher positive predictive value (+11.6%, P = .035) and specificity (+5.6%, P = .046) of the diagnostic test. Future studies are merited to investigate the diagnostic accuracy of the questionnaire in other populations and settings.


Asunto(s)
Úlcera de la Pierna/diagnóstico , Encuestas y Cuestionarios , Humanos , Prevalencia , Sensibilidad y Especificidad
9.
Case Rep Dermatol ; 8(1): 42-51, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27293393

RESUMEN

Cutis laxa is a rare disease characterized by abnormal skin wrinkling and laxity, due to decreased elastin synthesis or structural extracellular matrix defects. We have explored elastin metabolism in a case of adult onset cutis laxa localized to the upper body of a woman. For this purpose, we obtained skin biopsies from affected and unaffected skin areas of the patient and analyzed these with microscopy, polymerase chain reaction, western blotting and cell culture experiments. Skin from the affected area lacked elastin fibers in electron microscopy but had higher mRNA expression of elastin and total RNA. Levels of an apparent tropoelastin degradation product were higher in the affected area. Fibroblast cultures from the affected area were able to produce elastin and showed higher proliferation and survival after oxidative and UVB stress compared to fibroblasts from the unaffected area. In conclusion, we report a case of acquired localized cutis laxa with a lack of elastic fibers in the skin of the patient's upper body. The lack of elastic fibers in the affected skin was combined with increased mRNA expression and protein levels of elastin. These findings indicate that elastin synthesis was increased but did not lead to deposited elastic fibers in the tissue.

10.
Int J Dermatol ; 47(9): 891-3, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18937650

RESUMEN

The use of teledermatology as an adjunct to conventional clinical dermatology on the Faroe Islands is described. The service is based on a nurse-led dermatological clinic, and teledermatology is combined with specialist visits for more complex diagnosis or procedures.


Asunto(s)
Dermatología/métodos , Enfermedades de la Piel/diagnóstico , Telemedicina/métodos , Dinamarca , Femenino , Humanos , Masculino , Consulta Remota/estadística & datos numéricos , Enfermedades de la Piel/terapia , Telemedicina/estadística & datos numéricos
13.
Lasers Surg Med ; 36(2): 79-84, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15704160

RESUMEN

BACKGROUND AND OBJECTIVES: Carbon dioxide (CO(2)) laser resurfacing is primarily performed on photodamaged facial skin where patients are further exposed to ultraviolet radiation (UVR) postoperatively. We examined whether pre- and postoperative UVR influences the development of CO(2) laser-induced side effects. STUDY DESIGN/MATERIALS AND METHODS: Hairless mice (n = 211) were treated with a Sharplan CO(2) laser with FeatherTouch scanner. Simulated solar irradiation was administered either preoperatively or pre- and postoperatively. Skin end-points (wounds, texture changes, and pigmentary changes) were evaluated blinded by clinical evaluations, skin reflectance spectroscopy, and histological examinations. RESULTS: Pre- and postoperative UVR exposed mice obtained higher clinical scores of wounds (P < 0.02) and texture changes (P < 0.01) and developed more heavy fibrosis than mice treated with laser but no UVR. UVR exposure after CO(2) laser treatment induced significant hyperpigmentation compared to unexposed control mice (P < 0.003), whereas CO(2) laser treatment itself did not induce pigmentary changes. CONCLUSIONS: UVR increases in an animal model the occurrence of postoperative side effects from CO(2) laser resurfacing.


Asunto(s)
Dióxido de Carbono , Hiperpigmentación/patología , Hiperpigmentación/radioterapia , Terapia por Láser , Rayos Ultravioleta/efectos adversos , Animales , Modelos Animales de Enfermedad , Femenino , Rayos Láser/efectos adversos , Ratones , Ratones Pelados , Probabilidad , Valores de Referencia , Factores de Riesgo , Sensibilidad y Especificidad , Análisis Espectral/métodos , Estadísticas no Paramétricas , Cicatrización de Heridas/fisiología , Cicatrización de Heridas/efectos de la radiación
14.
Lasers Surg Med ; 35(1): 58-61, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15278929

RESUMEN

BACKGROUND AND OBJECTIVES: To examine whether carbon dioxide (CO2) laser treatment has a carcinogenic potential or may influence ultraviolet (UV)-induced carcinogenesis. STUDY DESIGN/MATERIALS AND METHODS: Hairless mice (n = 211) were treated with a Sharplan CO2 laser with FeatherTouch scanner. Simulated solar irradiations were administrated either pre-operatively or pre- and post-operatively. Weekly clinical assessments of skin tumors were performed blinded during the entire observation period of 12 months. RESULTS: No tumors appeared (a) in mice just treated with CO2 laser, (b) in mice exposed to UV irradiation only before CO2 laser treatment or (c) in untreated control mice. Tumors developed in CO2 laser treated mice that were exposed to UV-irradiation both pre- and post-operatively and in UV-irradiated control mice. The time to first, second, and third tumors ranged from 18 to 20 weeks and no significant differences were demonstrated. CONCLUSIONS: CO2 laser treatment does not have a carcinogenic potential in itself, nor does CO2 laser treatment influence UV-induced carcinogenesis.


Asunto(s)
Técnicas Cosméticas/efectos adversos , Rayos Láser/efectos adversos , Neoplasias Inducidas por Radiación/etiología , Neoplasias Cutáneas/etiología , Animales , Dióxido de Carbono , Femenino , Ratones , Ratones Pelados
15.
Acta Derm Venereol ; 84(6): 459-62, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15844637

RESUMEN

Neurosyphilis is now a rare disease in the developed countries. In Denmark 92 cases of neurosyphilis were identified in the period 1980-1997. We obtained the hospital records for 77 of these patients and studied the clinical presentation, treatment and result of the treatment. Most patients were treated with penicillin by the intramuscular or intravenous route, but the amounts and duration of the antibiotic treatment varied a lot among the patients. All patients treated with intravenous penicillin were cured.


Asunto(s)
Neurosífilis/epidemiología , Antibacterianos/uso terapéutico , Daño Encefálico Crónico/microbiología , Dinamarca/epidemiología , Esquema de Medicación , Femenino , Humanos , Incidencia , Inyecciones Intramusculares , Inyecciones Intravenosas , Masculino , Persona de Mediana Edad , Neurosífilis/diagnóstico , Neurosífilis/tratamiento farmacológico , Penicilinas/uso terapéutico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...